Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1991 Apr;50(4):267–269. doi: 10.1136/ard.50.4.267

Scleroderma and survival.

A J Silman 1
PMCID: PMC1004401  PMID: 2029211

Full text

PDF
267

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnett A. J., Miller M. H., Littlejohn G. O. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol. 1988 Feb;15(2):276–283. [PubMed] [Google Scholar]
  2. Barnett A. J. Scleroderma (progressive systemic sclerosis): progress and course based on a personal series of 118 cases. Med J Aust. 1978 Aug 12;2(4):129–134. doi: 10.5694/j.1326-5377.1978.tb131413.x. [DOI] [PubMed] [Google Scholar]
  3. Dalziel J. A., Wilcock G. K. Progressive systemic sclerosis in the elderly. Postgrad Med J. 1979 Mar;55(641):192–193. doi: 10.1136/pgmj.55.641.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Eason R. J., Tan P. L., Gow P. J. Progressive systemic sclerosis in Auckland: a ten year review with emphasis on prognostic features. Aust N Z J Med. 1981 Dec;11(6):657–662. doi: 10.1111/j.1445-5994.1981.tb03542.x. [DOI] [PubMed] [Google Scholar]
  5. FARMER R. G., GIFFORD R. W., Jr, HINES E. A., Jr Prognostic significance of Raynaud's phenomenon and other clinical characteristics of systemic scleroderma. A study of 271 cases. Circulation. 1960 Jun;21:1088–1095. doi: 10.1161/01.cir.21.6.1088. [DOI] [PubMed] [Google Scholar]
  6. Giordano M., Valentini G., Migliaresi S., Picillo U., Vatti M. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol. 1986 Oct;13(5):911–916. [PubMed] [Google Scholar]
  7. Hodkinson H. M. Scleroderma in the elderly, with special reference to the CRST syndrome. J Am Geriatr Soc. 1971 Mar;19(3):224–228. doi: 10.1111/j.1532-5415.1971.tb02625.x. [DOI] [PubMed] [Google Scholar]
  8. LeRoy E. C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T. A., Jr, Rowell N., Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988 Feb;15(2):202–205. [PubMed] [Google Scholar]
  9. Lee P., Alderdice C., Wilkinson S., Keystone E. C., Urowitz M. B., Gladman D. D. Malignancy in progressive systemic sclerosis--association with breast carcinoma. J Rheumatol. 1983 Aug;10(4):665–666. [PubMed] [Google Scholar]
  10. Masi A. T. Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol. 1988 Jun;15(6):894–898. [PubMed] [Google Scholar]
  11. Medsger T. A., Jr, Masi A. T. Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients. J Chronic Dis. 1973 Oct;26(10):647–660. doi: 10.1016/0021-9681(73)90054-4. [DOI] [PubMed] [Google Scholar]
  12. Peters-Golden M., Wise R. A., Hochberg M., Stevens M. B., Wigley F. M. Incidence of lung cancer in systemic sclerosis. J Rheumatol. 1985 Dec;12(6):1136–1139. [PubMed] [Google Scholar]
  13. RODNAN G. P. The natural history of progressive systemic sclerosis (diffuse scleroderma). Bull Rheum Dis. 1963 Feb;13:301–304. [PubMed] [Google Scholar]
  14. Reveille J. D., Bartolucci A., Alarcón G. S. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum. 1990 Jan;33(1):37–48. doi: 10.1002/art.1780330105. [DOI] [PubMed] [Google Scholar]
  15. Roumm A. D., Medsger T. A., Jr Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum. 1985 Dec;28(12):1336–1340. doi: 10.1002/art.1780281204. [DOI] [PubMed] [Google Scholar]
  16. Rowell N. R. The prognosis of systemic sclerosis. Br J Dermatol. 1976 Jul;95(1):57–60. doi: 10.1111/j.1365-2133.1976.tb15535.x. [DOI] [PubMed] [Google Scholar]
  17. Silman A., Jannini S., Symmons D., Bacon P. An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol. 1988 Aug;27(4):286–290. doi: 10.1093/rheumatology/27.4.286. [DOI] [PubMed] [Google Scholar]
  18. Symmons D. P., Coppock J. S., Bacon P. A., Bresnihan B., Isenberg D. A., Maddison P., McHugh N., Snaith M. L., Zoma A. S. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Q J Med. 1988 Nov;69(259):927–937. [PubMed] [Google Scholar]
  19. TUFFANELLI D. L., WINKELMANN R. K. Systemic scleroderma, A clinical study of 727 cases. Arch Dermatol. 1961 Sep;84:359–371. doi: 10.1001/archderm.1961.01580150005001. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES